GCN2 deficiency protects mice from denervation-induced skeletal muscle atrophy via inhibiting FoxO3a nuclear translocation
GCN2 deficiency protects mice from denervation-induced skeletal muscle atrophy via inhibiting FoxO3a nuclear translocation作者机构:College of Life Science University of Chinese Academy ofSciences Beijing 100049 China National Laboratory of Biomacromolecules Institute of BiophysicsChinese Academy of Sciences Beijing 100101 China
出 版 物:《Protein & Cell》 (蛋白质与细胞(英文版))
年 卷 期:2018年第9卷第11期
页 面:966-970页
核心收录:
学科分类:090603[农学-临床兽医学] 0710[理学-生物学] 07[理学] 09[农学] 0906[农学-兽医学] 071002[理学-动物学]
基 金:国家自然科学基金 Chinese Academy of Sciences(Hundred Talents Program)
摘 要:Dear Editor Several recent clinical studies have indicated that dietary supplementation with branched-chain amino acids (BCAA), particularly with leucine, is an effective anti-atrophic therapy (Bauer et al., 2015; Tsien et al., 2015; English et al., 2016). In animal models, BCAA can prevent denervation (Ribeiro et al., 2015), hindlimb suspension (Maki et al., 2012; Jang et al., 2015) or dexamethasone-induced (Yamamoto et al., 2010) muscle atrophy. General control nonderepressible 2 kinase (GCN2) is a well-known amino-acid sensor. Under conditions of amino-acid deprivation, the increased level of uncharged transfer RNA (tRNA) activates GCN2 through binding to the histadyl-tRNA synthetase-like domain (Wek et al., 1995). Upon activation, GCN2 phosphorylates eukaryotic initiation factor 2 alpha at Ser51, which leads to translational arrest and restoration of amino acid home- ostasis (Wek et al., 1995; Sood et al., 2000). As amino acids are potent modulators of protein turnover in skeletal muscle, we proposed that GCN2 may affect denervation-induced muscle atrol0hv, but the detail mechanism remains unclear.